BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5443519)

  • 1. [Evaluation of the pituitary reserve after the introduction of Y90 into the sella turcica].
    Monfardini S; Bonadonna G
    Minerva Med; 1970 Apr; 61(31):1625-34. PubMed ID: 5443519
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications and results of the Y90 hypophysectomy.
    Zoltan L; Toth S; Simon L
    Minerva Neurochir; 1969; 13(3):235-6. PubMed ID: 5382573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pituitary destruction with yttrium 90 or cryotherapy in 3 cases of advanced breast cancer].
    Abbes M; Bourgeon G; Paillaud F; Juillard G; Kermarec J; Cambon P; Namer M
    Ann Chir; 1972 May; 26(9):521-31. PubMed ID: 5055335
    [No Abstract]   [Full Text] [Related]  

  • 4. Double major ablation for mammary carcinoma.
    Hutton I
    Proc R Soc Med; 1973 Sep; 66(9):903-4. PubMed ID: 4805095
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the use of isotope hypophysectomy with yttrium 90 in mammary neoplasms].
    Oproiu A
    Stud Cercet Endocrinol; 1973; 24(2):125-30. PubMed ID: 4690424
    [No Abstract]   [Full Text] [Related]  

  • 6. [Elimination of urinary steroids and metopirone test following hypophysectomy for hormone-dependent cancer].
    Soulairac A; Talairach J; Schaub C; Aymard N; Bonis A; Szikla G
    Ann Endocrinol (Paris); 1967; 28(1):101-10. PubMed ID: 4862763
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled clinical trial to compare transethidal hypophysectomy with yttrium implant of the pituitary in the treatment of advanced breast cancer.
    Roberts MM; Richards SH; Gleave EN; Stewart HJ; Forrest AP; Joslin CA; Jones V; Boyns A; Campbell H
    Br J Surg; 1969 Aug; 56(8):615-6. PubMed ID: 4894617
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of stereotaxic surgery to the normal pituitary gland, pituitary tumor and parasellar diseases].
    Shintani A; Kuwayama A; Zeryas NT
    No To Shinkei; 1971 Aug; 23(8):881-7. PubMed ID: 4937635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of breast cancers].
    Chauvergne J; Hugues A; Touchard J; Simon G
    Bord Med; 1971 May; 4(5):1467-98. PubMed ID: 5569948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of the metastazing breast carcinoma].
    Klein U; Pabst HW
    Munch Med Wochenschr; 1967 Sep; 109(35):1813-21. PubMed ID: 5631332
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pituitary inhibition and destruction by stereotaxic implantation of radioactive material. (Technics, results, indications)].
    Cohadon F
    J Med Bord; 1967 Sep; 144(9):1313-20. PubMed ID: 4915455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Response of plasma cortisol to lysine-vasopressin administration. Comparative study with other hypothalamo-pituitary-adrenal function tests].
    Gonzalez Barcena D; Canceso Perez C; Ponce Zavala L; Chavez de la Cruz R
    Prensa Med Mex; 1970; 35(5):213-7. PubMed ID: 5517097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)].
    GOFFRINI P; FESANI F; PERACCHIA A
    Arch Ital Chir; 1959; 85():269-302. PubMed ID: 13850467
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proceedings: Value of hypophysectomy in the treatment of metastatic osteosis prostatic origin].
    Grasset D; Navratil H
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):420. PubMed ID: 4804414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of treatment of advanced cancers of the breast by intrapituitary implantation of radioactive yttrium].
    Fasching W; Wense G; Zängl A
    Bull Soc Int Chir; 1974 Mar; 33(2):81-4. PubMed ID: 4136112
    [No Abstract]   [Full Text] [Related]  

  • 16. [DISCUSSIONS ON MAMMARY CANCER. 6. STATE OF PATIENTS WITH METASTATIC MAMMARY CANCER AFTER TREATMENT BY HYPOPHYSECTOMY WITH RADIOACTIVE YTTRIUM].
    COENGRACHT JM; LANKESTER J; PLAATS GJ; DE LANGE SA; TOUBER JL; FRENKEL M; VAN DER WERF AJ
    Jaarb Kankeronderz Kankerbestrijd Ned; 1963; 13():75-88. PubMed ID: 14184131
    [No Abstract]   [Full Text] [Related]  

  • 17. [RESULTS OF HYPOPHYSECTOMY WITH RADIOACTIVE GOLD AND YTTRIUM 90].
    WENSE G; ZAENGL A
    Bull Soc Int Chir; 1964; 23():81-6. PubMed ID: 14139420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypophysiolysis by radioactive yttrium implantation in treatment of advanced breast cancer: 10 years' record].
    Juret P
    Probl Actuels Endocrinol Nutr; 1969; 13():373-93. PubMed ID: 5404030
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of intrapituitary yttrium 90 implantation in the treatment of advanced breast cancer].
    Juret P
    Therapeutique; 1971 Feb; 47(2):163-5. PubMed ID: 5548427
    [No Abstract]   [Full Text] [Related]  

  • 20. [Elimination of the hypophysis in metastasizing breast carcinoma].
    Escher F
    Ther Umsch; 1971 Mar; 28(3):128-35. PubMed ID: 5090191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.